1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Belzutifan with lenvatinib for treating advanced renal cell carcinoma after a PD-1 or PD-L1 inhibitor ID 6476

Awaiting development [GID-TA11584] Expected publication date: TBC

  • Project information
  • Project documents

30655-Belzutifan-and-Lenvatinib-for-Renal-Cell-Carcinoma-V1.0-MAY2024-NON-CONF.pdf (nihr.ac.uk)